ERBB2 and breast carcinoma: Furthermore, in patients with breast cancer, HOPX DNA methylation is significantly related to human epidermal growth factor receptor 2 (HER2) positivity and advanced lymph node metastasis, and it predicts an unfavorable clinical outcome [62].